Showing results (111-120 of 137) with videos related to
Sort By:
Pageof 14
Rheumatology and Therapy|June 9, 2023
Hematologic Malignancy Risk in Inflammatory Arthritis Patients Treated with TNF Inhibitors: The Real-Life Data from the HUR-BIO RegistryEmine Duran, Zeynep Ozge Ozturk, Emre Bilgin, et al.Clinical and Experimental Rheumatology|September 8, 2020
Biological and targeted-synthetic disease-modifying anti-rheumatic drugs with concomitant methotrexate or leflunomide in rheumatoid arthritis: real-life TReasure prospective dataGezmiş Kimyon, Umut Kalyoncu, Sedat Kiraz, et al.Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|May 20, 2021
Physicians' Biological Drug Preference in Patients With Rheumatoid Arthritis and Spondyloarthritis With a History of Malignancy: Perspectives From the Treasure DatabaseEmre Tekgoz, Seda Colak, Kubra G Yardimci, et al.European Journal of Rheumatology|January 18, 2023
The First Effect of COVID-19 Pandemic on Starting Biological Disease Modifying Anti-Rheumatic Drugs: Outcomes from the TReasure Real-Life DatabaseNilüfer Alpay Kanıtez, Sedat Kiraz, Ediz Dalkılıç, et al.Clinical and Experimental Rheumatology|June 29, 2022
Clinical and laboratory factors associated with bamboo spine in patients with axial spondyloarthritis: are there clues for bamboo spine?Pamir Atagündüz, Sedat Kiraz, Servet Akar, et al.Rheumatology International|April 29, 2022
Tuberculin skin test before biologic and targeted therapies: does the same rule apply for all?Ufuk İlgen, Ömer Karadağ, Hakan Emmungil, et al.Clinical and Experimental Rheumatology|May 2, 2012
The cost of care of rheumatoid arthritis and ankylosing spondylitis patients in tertiary care rheumatology units in TurkeySimten Malhan, Salih Pay, Sebnem Ataman, et al.Archives of Rheumatology|December 4, 2023
Epidemiological characteristics of hepatitis B and C in patients with inflammatory arthritis: Implications from treasure databaseEmine Duygu Ersözlü, Mustafa Ekici, Belkis Nihan Coşkun, et al.Turkish Journal of Medical Sciences|February 21, 2021
Preferences of inflammatory arthritis patients for biological disease-modifying antirheumatic drugs in the first 100 days of the COVID-19 pandemicUmut Kalyoncu, Yavuz Pehlivan, Servet Akar, et al.Rheumatology (Oxford, England)|July 23, 2013
Impaired quality of life, disability and mental health in Takayasu's arteritisNeslihan Yilmaz, Meryem Can, Fatma Alibaz Oner, et al.Pageof 14